Sökning: WFRF:(Corbalan Ramon)
> (2019) >
Ticagrelor in Patie...
-
Steg, P. GabrielUniv Paris, French Alliance Cardiovasc Trials, Dept Hosp Univ FIRE, Hop Bichat,INSERM,U1148, Paris, France;Hop St Antoine, AP HP, Paris, France;Imperial Coll, Natl Heart & Lung Inst, London, England;Royal Brompton Hosp, London, England
(författare)
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
- Artikel/kapitelEngelska2019
Förlag, utgivningsår, omfång ...
-
MASSACHUSETTS MEDICAL SOC,2019
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-395718
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-395718URI
-
https://doi.org/10.1056/NEJMoa1908077DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Patients with stable coronary artery disease and diabetes were randomly assigned to receive either ticagrelor plus aspirin or placebo plus aspirin. At 40 months, the incidence of the composite efficacy outcome of cardiovascular death, myocardial infarction, or stroke was lower with ticagrelor than with placebo; the frequency of major bleeding was higher with ticagrelor. Background Patients with stable coronary artery disease and diabetes mellitus who have not had a myocardial infarction or stroke are at high risk for cardiovascular events. Whether adding ticagrelor to aspirin improves outcomes in this population is unclear. Methods In this randomized, double-blind trial, we assigned patients who were 50 years of age or older and who had stable coronary artery disease and type 2 diabetes mellitus to receive either ticagrelor plus aspirin or placebo plus aspirin. Patients with previous myocardial infarction or stroke were excluded. The primary efficacy outcome was a composite of cardiovascular death, myocardial infarction, or stroke. The primary safety outcome was major bleeding as defined by the Thrombolysis in Myocardial Infarction (TIMI) criteria. Results A total of 19,220 patients underwent randomization. The median follow-up was 39.9 months. Permanent treatment discontinuation was more frequent with ticagrelor than placebo (34.5% vs. 25.4%). The incidence of ischemic cardiovascular events (the primary efficacy outcome) was lower in the ticagrelor group than in the placebo group (7.7% vs. 8.5%; hazard ratio, 0.90; 95% confidence interval [CI], 0.81 to 0.99; P=0.04), whereas the incidence of TIMI major bleeding was higher (2.2% vs. 1.0%; hazard ratio, 2.32; 95% CI, 1.82 to 2.94; P<0.001), as was the incidence of intracranial hemorrhage (0.7% vs. 0.5%; hazard ratio, 1.71; 95% CI, 1.18 to 2.48; P=0.005). There was no significant difference in the incidence of fatal bleeding (0.2% vs. 0.1%; hazard ratio, 1.90; 95% CI, 0.87 to 4.15; P=0.11). The incidence of an exploratory composite outcome of irreversible harm (death from any cause, myocardial infarction, stroke, fatal bleeding, or intracranial hemorrhage) was similar in the ticagrelor group and the placebo group (10.1% vs. 10.8%; hazard ratio, 0.93; 95% CI, 0.86 to 1.02). Conclusions In patients with stable coronary artery disease and diabetes without a history of myocardial infarction or stroke, those who received ticagrelor plus aspirin had a lower incidence of ischemic cardiovascular events but a higher incidence of major bleeding than those who received placebo plus aspirin. (Funded by AstraZeneca; THEMIS ClinicalTrials.gov number, NCT01991795.).
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Bhatt, Deepak L.Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA;Harvard Med Sch, Boston, MA 02115 USA
(författare)
-
Simon, TabassomeHop St Antoine, AP HP, Paris, France;Dept Clin Pharmacol, Unite Rech Clin, Paris, France;Sorbonne Univ, Paris, France
(författare)
-
Fox, KimImperial Coll, Natl Heart & Lung Inst, London, England;Royal Brompton Hosp, London, England
(författare)
-
Mehta, Shamir R.Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada;McMaster Univ, Hamilton, ON, Canada
(författare)
-
Harrington, Robert A.Stanford Univ, Stanford, CA 94305 USA
(författare)
-
Held, Claes,1956-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)clahe947
(författare)
-
Andersson, MarielleAstraZeneca BioPharmaceut Res & Dev, Molndal, Sweden
(författare)
-
Himmelmann, AndersAstraZeneca BioPharmaceut Res & Dev, Molndal, Sweden
(författare)
-
Ridderstråle, WilhelmAstraZeneca BioPharmaceut Res & Dev, Molndal, Sweden
(författare)
-
Leonsson-Zachrisson, MariaAstraZeneca BioPharmaceut Res & Dev, Molndal, Sweden
(författare)
-
Liu, YuyinBaim Inst Clin Res, Boston, MA USA
(författare)
-
Opolski, GrzegorzMed Univ Warsaw, Dept Cardiol, Warsaw, Poland
(författare)
-
Zateyshchikov, DmitryCity Clin Hosp 51, State Hlth Care Agcy, Moscow, Russia
(författare)
-
Ge, JunboFudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai, Peoples R China
(författare)
-
Nicolau, Jose C.Univ Sao Paulo, Fac Med, Hosp Clin, Inst Coracao, Sao Paulo, Brazil
(författare)
-
Corbalan, RamonPontificia Univ Catolica Chile, Fac Med, Santiago, Chile
(författare)
-
Cornel, Jan H.Alkmaar, Dutch Network Cardiovasc Res, Northwest Clin, Utrecht, Netherlands;Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, Nijmegen, Netherlands
(författare)
-
Widimsky, PetrCharles Univ Prague, Cardioctr, Fac Med 3, Univ Hosp Kralovske Vinohrady, Prague, Czech Republic
(författare)
-
Leiter, Lawrence A.Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada
(författare)
-
Univ Paris, French Alliance Cardiovasc Trials, Dept Hosp Univ FIRE, Hop Bichat,INSERM,U1148, Paris, France;Hop St Antoine, AP HP, Paris, France;Imperial Coll, Natl Heart & Lung Inst, London, England;Royal Brompton Hosp, London, EnglandBrigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA;Harvard Med Sch, Boston, MA 02115 USA
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:New England Journal of Medicine: MASSACHUSETTS MEDICAL SOC381:14, s. 1309-13200028-47931533-4406
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Steg, P. Gabriel
-
Bhatt, Deepak L.
-
Simon, Tabassome
-
Fox, Kim
-
Mehta, Shamir R.
-
Harrington, Robe ...
-
visa fler...
-
Held, Claes, 195 ...
-
Andersson, Marie ...
-
Himmelmann, Ande ...
-
Ridderstråle, Wi ...
-
Leonsson-Zachris ...
-
Liu, Yuyin
-
Opolski, Grzegor ...
-
Zateyshchikov, D ...
-
Ge, Junbo
-
Nicolau, Jose C.
-
Corbalan, Ramon
-
Cornel, Jan H.
-
Widimsky, Petr
-
Leiter, Lawrence ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
New England Jour ...
- Av lärosätet
-
Uppsala universitet